Public trial registry of the CCC-Munich

Trial GPPAD-03-POInT

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
GPPAD-03-POInT
World
Full title
:

GPPAD-POInT (Global Platform of Autoimmune Diabetes – Primary Oral Insulin Trial)
Oral Insulin Therapy for Prevention of Autoimmune Diabetes

Prevention of diabetes in very young children (age 4 to 7 month) at high
genetic risk for type 1 diabetes with oral insulin therapy

World
Responsible organization
:
Diabetes Forschung MRI Kölner Platz 1 80804 München Germany
Indications
Classification Code Description
ICD-10-GM Z13.1 Spezielle Verfahren zur Untersuchung auf Diabetes mellitus
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2017-11-06
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Sonstige - Therapieart: andere

Participants
Function Prename Surname Organization
World Responsible contact Anette Ziegler Diabetes Forschung MRI Kölner Platz 1 80804 München Germany Magnifier